
Pfizer (PFE) announced Monday that it is ending development of its daily weight-loss pill following a liver injury to a patient participating in a trial.
Latest News “Stay informed with breaking news, world news, US news, politics, business, technology, and more at latest news.
Auto Added by WPeMatico
Pfizer (PFE) announced Monday that it is ending development of its daily weight-loss pill following a liver injury to a patient participating in a trial.